Saiyed Atiq Raza Sells 20,839 Shares of Arteris (NASDAQ:AIP) Stock

Key Points

  • Arteris director Saiyed Atiq Raza sold 20,839 shares on June 3 at an average price of $37.39, generating about $779,170 and reducing his direct stake by 12.96% to 140,000 shares.
  • Raza has been active in selling Arteris stock recently, including transactions of 70,000 shares on June 1 and 90,000 shares on May 1, along with additional sales in April.
  • Arteris reported better-than-expected quarterly results, with EPS of -$0.03 versus an expected -$0.08 and revenue of $22.94 million versus $21.03 million, while analysts currently hold a consensus rating of Hold with a $37.75 target price.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 20,839 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $37.39, for a total value of $779,170.21. Following the completion of the transaction, the director directly owned 140,000 shares in the company, valued at $5,234,600. The trade was a 12.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Saiyed Atiq Raza also recently made the following trade(s):

  • On Monday, June 1st, Saiyed Atiq Raza sold 70,000 shares of Arteris stock. The stock was sold at an average price of $36.02, for a total value of $2,521,400.00.
  • On Friday, May 1st, Saiyed Atiq Raza sold 90,000 shares of Arteris stock. The stock was sold at an average price of $28.71, for a total value of $2,583,900.00.
  • On Monday, April 20th, Saiyed Atiq Raza sold 17,060 shares of Arteris stock. The stock was sold at an average price of $22.16, for a total value of $378,049.60.
  • On Friday, April 17th, Saiyed Atiq Raza sold 72,940 shares of Arteris stock. The stock was sold at an average price of $22.16, for a total value of $1,616,350.40.

Arteris Stock Performance




Shares of Arteris stock opened at $37.19 on Friday. The company has a market capitalization of $1.72 billion, a PE ratio of -47.08 and a beta of 1.98. Arteris, Inc. has a 12 month low of $7.56 and a 12 month high of $38.99. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17. The stock's fifty day simple moving average is $27.36 and its 200 day simple moving average is $19.79.

Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.05. The business had revenue of $22.94 million for the quarter, compared to analyst estimates of $21.03 million. On average, research analysts predict that Arteris, Inc. will post -0.54 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Wall Street Zen cut Arteris from a "buy" rating to a "hold" rating in a report on Saturday, May 2nd. Rosenblatt Securities increased their target price on Arteris from $20.00 to $38.00 and gave the stock a "buy" rating in a report on Wednesday, May 13th. Weiss Ratings cut Arteris from a "sell (d-)" rating to a "sell (e+)" rating in a report on Wednesday, May 13th. TD Cowen increased their target price on Arteris from $22.00 to $40.00 and gave the stock a "buy" rating in a report on Wednesday, May 13th. Finally, Northland Securities set a $38.00 target price on Arteris in a report on Wednesday, May 13th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Arteris has a consensus rating of "Hold" and a consensus target price of $37.75.

Check Out Our Latest Analysis on AIP

Hedge Funds Weigh In On Arteris

A number of large investors have recently modified their holdings of the business. Needham Investment Management LLC raised its holdings in shares of Arteris by 2.6% in the 4th quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company's stock valued at $52,878,000 after purchasing an additional 86,500 shares during the period. Franklin Resources Inc. raised its holdings in shares of Arteris by 6.2% in the 4th quarter. Franklin Resources Inc. now owns 1,743,031 shares of the company's stock valued at $27,017,000 after purchasing an additional 101,646 shares during the period. Vanguard Group Inc. raised its holdings in shares of Arteris by 8.2% in the 3rd quarter. Vanguard Group Inc. now owns 1,594,402 shares of the company's stock valued at $16,103,000 after purchasing an additional 120,947 shares during the period. Westerly Capital Management LLC raised its holdings in shares of Arteris by 109.6% in the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company's stock valued at $14,392,000 after purchasing an additional 745,000 shares during the period. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Arteris by 144.7% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company's stock valued at $15,696,000 after purchasing an additional 598,840 shares during the period. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Arteris?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Arteris and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles